InvestorsHub Logo
Followers 27
Posts 4249
Boards Moderated 0
Alias Born 03/23/2016

Re: realfast95 post# 1074

Friday, 01/13/2017 1:53:00 PM

Friday, January 13, 2017 1:53:00 PM

Post# of 2104
I do not know who Bret Jensen is, but he sure writes a silly and factually incorrect synopsis. I say factually incorrect because how does one describe the Novartis deal without a mention of the $650mil. Then, how does one say with a seemingly straight face that Conatus is "many quarters from seeing progress on Emricasan."

So, this guys definition of "many quarters" is 4? or 5?. Lots of data will start to be published and presented in first half of 2018.

No one has any patience. At least this Jensen guy told us why he is hoping CNAT doesn't move much anytime soon since he loses his shares when it goes over 7.50.